Tailoring TIMPs for selective metalloproteinase inhibition

The Cancer Degradome: Proteases and Cancer Biology

Volumn , Issue , 2008, Pages 787-810

  Nagase, Hideaki ^a   Murphy, Gillian ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349373444     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-69057-5_37     Document Type: Chapter

References (56)

1. Amour A, Slocombe P M, Webster A et al. (1998) TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435: 39-44
2. Amour A, Knight C G, Webster A et al. (2000) The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 473: 275-279
3. Amour A, Knight C G, EnglishWR et al. (2002) The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. FEBS Lett 524: 154-158
4. Atkinson S J, Crabbe T, Cowell S, Ward R V, Butler M J, Sato H, Seiki M, Reynolds J J, Murphy G. (1995) Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 270: 30479-30485
5. Baker A H, Edwards D R and Murphy G. (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115: 3719-3727
6. Bigg H F, Shi Y E, Liu Y L E et al. (1997) Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. J Biol Chem 272: 15496-15500
7. Bigg H F, Morrison C J, Butler G S et al. (2001) Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1- matrix metalloproteinase. Cancer Res 61: 3610-3618
8. Black R A. (2002) Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol 34: 1-5
9. Brew K, Dinakarpandian D and Nagase H. (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477: 267-283
10. Butler G S, Butler M J, Atkinson S J et al. (1998) The TIMP2 membrane type 1 metalloproteinase receptor regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273: 871-880
11. Butler G S, Apte S S, Willenbrock F et al. (1999) Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions. J Biol Chem 274: 10846-10851
12. Fata J E, Leco K J, Voura E B et al. (2001) Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest 108: 831-841
13. Fernandez-Catalan C, Bode W, Huber R, et al. (1998) Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases- 2, the soluble progelatinase A receptor. EMBO J 17: 5238-5248
14. Goldberg G I, Strongin A, Collier I E et al. (1992) Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267: 4583-4591
15. Gomis-Ruth F-X, Maskos K, Betz M et al. (1997) Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389: 77-79
16. Hamze A B, Wei S, Bahudhanapati H et al. (2007) Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors. Protein Sci 16:1905-1913
17. Hashimoto G, Aoki T, Nakamura H et al. (2001) Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, -2, -3 and -4). FEBS Lett 494: 192-195
18. Hernandez-Barrantes S, Shimura Y, Soloway P D et al. (2001) Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP. Biochem Biophys Res Commun 281(1): 126-130
19. Huang W, Meng Q, Suzuki K et al. (1997) Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases. J Biol Chem 272: 22086-22091
20. Hutton M, Willenbrock F, Brocklehurst K et al. (1998) Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A: evidence for the existence of a low-affinity intermediate. Biochemistry 37: 10094-10098
21. Jin G, Huang X, Black R et al. (2002) A continuous fluorimetric assay for tumor necrosis factoralpha converting enzyme. Anal Biochem 302: 269-275
22. Kashiwagi M, Tortorella M, Nagase H et al. (2001) TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem 276: 12501-12504
23. Leco K J, Waterhouse P, Sanchez O H et al. (2001) Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 108(6): 817-829
24. Loechel F, Fox J W, Murphy G et al. (2000) ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 278: 511-515
25. Lee M H, Verma V, Maskos K et al. (2002a) The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3. FEBS Lett 520(1-3): 102-106
26. Lee M H, Verma V, Maskos K et al. (2002b) Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alphaconverting enzyme. Biochem J 364: 227-234
27. Lee M H, Rapti M and Murphy G. (2003a) Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase. J Biol Chem 278: 40224-40230
28. Lee M H, Dodds P, Verma V et al. (2003b) Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme. Biochem J 371: 369-376
29. Lee M H, Rapti M, Knauper V., Murphy G. (2004a) Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition. J Biol Chem 279, 17562-17569.
30. Lee M H, Rapti M, Murphy G. (2004b) Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme. J Biol Chem 279: 45121-45129
31. Lee M H, Rapti M, Murphy G. (2005) Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}- converting enzyme. J Biol Chem 280: 15967-15975
32. Maskos K, Fernandez-Catalan C, Huber R et al. (1998) Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A 95: 3408-3412
33. Meng Q, Malinovskii V, Huang W et al. (1999) Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1 residue of substrate. J Biol Chem 274: 10184-10189
34. Meng Q, Malinovskii V, Huang W, Hu Y J, Chung L, Nagase H, Bode W, Maskos K, Brew K, (1999) Residue 2 of TIMP-1 is a major determinant of afiinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P10 residue of substrate. J Biol Chem 274: 10184-10189
35. Mohammed F F, Smookler D S, Taylor S E et al. (2004) Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36: 969-977
36. Morgunova E, Tuuttila A, Bergmann U et al. (2002) Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc Natl Acad Sci U S A 99: 7414-7419
37. Murphy G, Houbrechts A, Cockett M I et al. (1991) The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30: 8097-8102
38. Nagase H. (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378(3-4): 151-160
39. Nagase H and Fields G B. (1996) Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides. Biopolymers 40: 399-416
40. Nagase H, Suzuki K, Cawston T E et al. (1997) Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1). Biochem J 325: 163-167
41. Nagase H, Visse R and Murphy G. (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573
42. OConnell J P, Willenbrock F, Docherty A J et al. (1994) Analysis of the role of the COOHterminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J Biol Chem 269: 14967-14973
43. Rapti M, Knauper V, Murphy G et al. (2006) Characterization of the AB loop region of TIMP-2. Involvement in pro-MMP-2 activation. J Biol Chem 28: 23386-23394
44. Rodriguez-Manzaneque J C, Westling J, Thai S N et al. (2002) ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem Biophys Res Commun 293: 501-508
45. Roghani M, Becherer J D, Moss M L, Atherton R E, Erdjument-Bromage H, Arribas J, Blackburn R K, Weskamp G, Tempst P, Blobel C P. (1999) Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J Biol Chem 274: 3531-3540
46. Schlondorff J, Lum L and Blobel C P. (2001) Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase. J Biol Chem 276: 14665-14674
47. Solomon A, Akabayov B, Frenkel A et al. (2007) Key feature of the catalytic cycle of TNF-alpha converting enzyme involves communication between distal protein sites and the enzyme catalytic core. Proc Natl Acad Sci U S A 104(12): 4931-4936
48. Troeberg L, Tanaka M, Wait R et al. (2002) E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A). Biochemistry 41: 15025-15035
49. Wei S, Chen Y, Chung L et al. (2003) Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors. J Biol Chem 278: 9831-9834
50. Wei S, Kashiwagi M, Kota S et al. (2005) Reactive site mutations in tissue inhibitor of metalloproteinase- 3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factoralpha- converting enzyme. J Biol Chem 280: 32877-32882
51. Willenbrock F, Crabbe T, Slocombe P M et al. (1993) The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry 32: 4330-4337
52. Williamson R A, Martorell G, Carr M D, Murphy G, Docherty A J P, Freedman R B, Feeney J. (1994) Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry 33: 11745-11759
53. Williamson R A, Hutton M, Vogt G et al. (2001) Tyrosine 36 plays a critical role in the interaction of the AB loop of tissue inhibitor of metalloproteinases-2 with matrix metalloproteinase-14. J Biol Chem 276: 32966-32970
54. Williamson R A, Hutton M, Vogt G et al. (2001) Tyrosine 36 plays a critical role in the interaction of the AB loop of tissue inhibitor of metalloproteinases-2 with matrix metalloproteinase-14. J Biol Chem 276: 32966-32970
55. Wingfield P T, Sax J K, Stahl S J et al. (1999) Biophysical and functional characterization of fulllength, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for the mechanism of TIMP functions. J Biol Chem 274: 21362-21368
56. Worley J R, Thompkins P B, Lee M H et al. (2003) Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Biochem J 372: 799-809.